The Mutational Landscape of SARS-CoV-2

dc.contributor.authorSaldivar-Espinoza Bryan
dc.contributor.authorGarcia-Segura Pol
dc.contributor.authorNovau-Ferré Nil
dc.contributor.authorMacip Guillem
dc.contributor.authorMartínez Ruben
dc.contributor.authorPuigbò Pere
dc.contributor.authorCereto-Massagué Adrià
dc.contributor.authorPujadas Gerard
dc.contributor.authorGarcia-Vallve Santiago
dc.contributor.organizationfi=biologian laitos|en=Department of Biology|
dc.contributor.organization-code1.2.246.10.2458963.20.77193996913
dc.converis.publication-id179870920
dc.converis.urlhttps://research.utu.fi/converis/portal/Publication/179870920
dc.date.accessioned2025-08-28T00:48:09Z
dc.date.available2025-08-28T00:48:09Z
dc.description.abstractMutation research is crucial for detecting and treating SARS-CoV-2 and developing vaccines. Using over 5,300,000 sequences from SARS-CoV-2 genomes and custom Python programs, we analyzed the mutational landscape of SARS-CoV-2. Although almost every nucleotide in the SARS-CoV-2 genome has mutated at some time, the substantial differences in the frequency and regularity of mutations warrant further examination. C>U mutations are the most common. They are found in the largest number of variants, pangolin lineages, and countries, which indicates that they are a driving force behind the evolution of SARS-CoV-2. Not all SARS-CoV-2 genes have mutated in the same way. Fewer non-synonymous single nucleotide variations are found in genes that encode proteins with a critical role in virus replication than in genes with ancillary roles. Some genes, such as spike (S) and nucleocapsid (N), show more non-synonymous mutations than others. Although the prevalence of mutations in the target regions of COVID-19 diagnostic RT-qPCR tests is generally low, in some cases, such as for some primers that bind to the N gene, it is significant. Therefore, ongoing monitoring of SARS-CoV-2 mutations is crucial. The SARS-CoV-2 Mutation Portal provides access to a database of SARS-CoV-2 mutations.
dc.identifier.jour-issn1661-6596
dc.identifier.olddbid206443
dc.identifier.oldhandle10024/189470
dc.identifier.urihttps://www.utupub.fi/handle/11111/45929
dc.identifier.urlhttps://doi.org/10.3390/ijms24109072
dc.identifier.urnURN:NBN:fi-fe2025082787359
dc.language.isoen
dc.okm.affiliatedauthorPuigbo, Pedro
dc.okm.discipline3111 Biomedicineen_GB
dc.okm.discipline3111 Biolääketieteetfi_FI
dc.okm.internationalcopublicationinternational co-publication
dc.okm.internationalityInternational publication
dc.okm.typeA1 ScientificArticle
dc.publisherMDPI
dc.publisher.countrySwitzerlanden_GB
dc.publisher.countrySveitsifi_FI
dc.publisher.country-codeCH
dc.relation.articlenumber9072
dc.relation.doi10.3390/ijms24109072
dc.relation.ispartofjournalInternational Journal of Molecular Sciences
dc.relation.issue10
dc.relation.volume24
dc.source.identifierhttps://www.utupub.fi/handle/10024/189470
dc.titleThe Mutational Landscape of SARS-CoV-2
dc.year.issued2023

Tiedostot

Näytetään 1 - 1 / 1
Ladataan...
Name:
ijms-24-09072.pdf
Size:
1.98 MB
Format:
Adobe Portable Document Format